A COMPUTATIONAL AND THEORETICAL APPROACH TO AZILSARTAN: A NOVEL ANGIOTENSIN II RECEPTOR BLOCKER
Shazia Parveen, Najmussehar, Sharique Ahmed, Nadeem Siddiqui*, Vivek Kumar4 and Shagufi Naza
ABSTRACT
Hypertension is a global health issue. Azilsartan belongs to a class of drugs known as angiotensin receptor blockers (ARBs) and is used to treat hypertension. Among all ARBs, azilsartan is proven to be more potent till date. Azilsartan is the latest ARB approved for hypertension with greater potency and minimal side effects. The present report is a summary on this class of antihypertensive azilsartan with emphasis on its computational study and spectral prediction.
[Full Text Article] [Download Certificate]